Year |
Citation |
Score |
2020 |
Criswell SR, Nielsen SS, Warden MN, Perlmutter JS, Moerlein SM, Sheppard L, Lenox-Krug J, Checkoway H, Racette BA. [11C]dihydrotetrabenazine Positron Emission Tomography in Manganese-Exposed Workers. Journal of Occupational and Environmental Medicine. PMID 32472844 DOI: 10.1097/Jom.0000000000001915 |
0.326 |
|
2018 |
Criswell SR, Warden MN, Searles Nielsen S, Perlmutter JS, Moerlein SM, Sheppard L, Lenox-Krug J, Checkoway H, Racette BA. Selective D2 receptor PET in manganese-exposed workers. Neurology. PMID 30097475 DOI: 10.1212/Wnl.0000000000006163 |
0.408 |
|
2017 |
Criswell SR, Nielsen SS, Warden M, Perlmutter JS, Moerlein SM, Flores HP, Huang J, Sheppard L, Seixas N, Checkoway H, Racette BA. [(18)F]FDOPA Positron Emission Tomography in Manganese-Exposed Workers. Neurotoxicology. PMID 28694016 DOI: 10.1016/J.Neuro.2017.07.004 |
0.341 |
|
2016 |
Eisenstein SA, Bogdan R, Love-Gregory L, Corral-Frías NS, Koller JM, Black KJ, Moerlein SM, Perlmutter JS, Barch DM, Hershey T. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status. Synapse (New York, N.Y.). PMID 27241797 DOI: 10.1002/Syn.21916 |
0.354 |
|
2015 |
Yue X, Bognar C, Zhang X, Gaehle GG, Moerlein SM, Perlmutter JS, Tu Z. Automated production of [(18)F]VAT suitable for clinical PET study of vesicular acetylcholine transporter. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 107: 40-46. PMID 26408913 DOI: 10.1016/J.Apradiso.2015.09.010 |
0.379 |
|
2015 |
Eisenstein SA, Gredysa DM, Antenor-Dorsey JA, Green L, Arbeláez AM, Koller JM, Black KJ, Perlmutter JS, Moerlein SM, Hershey T. Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity. Plos One. 10: e0133621. PMID 26192187 DOI: 10.1371/Journal.Pone.0133621 |
0.317 |
|
2015 |
Tian L, Xia Y, Flores HP, Campbell MC, Moerlein SM, Perlmutter JS. Neuroimaging Analysis of the Dopamine Basis for Apathetic Behaviors in an MPTP-Lesioned Primate Model. Plos One. 10: e0132064. PMID 26135399 DOI: 10.1371/Journal.Pone.0132064 |
0.346 |
|
2015 |
Eisenstein SA, Bischoff AN, Gredysa DM, Antenor-Dorsey JA, Koller JM, Al-Lozi A, Pepino MY, Klein S, Perlmutter JS, Moerlein SM, Black KJ, Hershey T. Emotional Eating Phenotype is Associated with Central Dopamine D2 Receptor Binding Independent of Body Mass Index. Scientific Reports. 5: 11283. PMID 26066863 DOI: 10.1038/Srep11283 |
0.307 |
|
2014 |
Black KJ, Snyder AZ, Mink JW, Tolia VN, Revilla FJ, Moerlein SM, Perlmutter JS. Spatial reorganization of putaminal dopamine D2-like receptors in cranial and hand dystonia. Plos One. 9: e88121. PMID 24520350 DOI: 10.1371/Journal.Pone.0088121 |
0.424 |
|
2014 |
Black KJ, Snyder AZ, Mink JW, Tolia VN, Revilla FJ, Moerlein SM, Perlmutter JS. Mean location in atlas space of peak [ 18 F]spiperone binding, by group (mm). Plos One. DOI: 10.1371/Journal.Pone.0088121.T001 |
0.32 |
|
2014 |
Black KJ, Snyder AZ, Mink JW, Tolia VN, Revilla FJ, Moerlein SM, Perlmutter JS. Coronal view of peak [ 18 F]spiperone binding in striatum in cranial and hand dystonia. Plos One. DOI: 10.1371/Journal.Pone.0088121.G002 |
0.362 |
|
2013 |
Karimi M, Moerlein SM, Videen TO, Su Y, Flores HP, Perlmutter JS. Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia Movement Disorders. 28: 2002-2006. PMID 24151192 DOI: 10.1002/Mds.25720 |
0.381 |
|
2013 |
Brown CA, Karimi MK, Tian L, Flores H, Su Y, Tabbal SD, Loftin SK, Moerlein SM, Perlmutter JS. Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques. Annals of Neurology. 74: 602-10. PMID 23686841 DOI: 10.1002/Ana.23939 |
0.386 |
|
2013 |
Eisenstein SA, Antenor-Dorsey JA, Gredysa DM, Koller JM, Bihun EC, Ranck SA, Arbeláez AM, Klein S, Perlmutter JS, Moerlein SM, Black KJ, Hershey T. A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol. Synapse (New York, N.Y.). 67: 748-56. PMID 23650017 DOI: 10.1002/Syn.21680 |
0.38 |
|
2013 |
Karimi M, Tian L, Brown CA, Flores HP, Loftin SK, Videen TO, Moerlein SM, Perlmutter JS. Validation of nigrostriatal positron emission tomography measures: critical limits. Annals of Neurology. 73: 390-6. PMID 23423933 DOI: 10.1002/Ana.23798 |
0.363 |
|
2012 |
Brown CA, Campbell MC, Karimi M, Tabbal SD, Loftin SK, Tian LL, Moerlein SM, Perlmutter JS. Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys. Experimental Neurology. 236: 190-7. PMID 22579525 DOI: 10.1016/J.Expneurol.2012.04.025 |
0.309 |
|
2012 |
Eisenstein SA, Koller JM, Piccirillo M, Kim A, Antenor-Dorsey JA, Videen TO, Snyder AZ, Karimi M, Moerlein SM, Black KJ, Perlmutter JS, Hershey T. Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET. Synapse (New York, N.Y.). 66: 770-80. PMID 22535514 DOI: 10.1002/Syn.21566 |
0.462 |
|
2012 |
Criswell SR, Perlmutter JS, Crippin JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels. Archives of Neurology. 69: 394-7. PMID 22410448 DOI: 10.1001/Archneurol.2011.771 |
0.329 |
|
2011 |
Criswell SR, Perlmutter JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced uptake of [¹⁸F]FDOPA PET in asymptomatic welders with occupational manganese exposure. Neurology. 76: 1296-301. PMID 21471467 DOI: 10.1212/Wnl.0B013E3182152830 |
0.362 |
|
2011 |
Karimi M, Moerlein SM, Videen TO, Luedtke RR, Taylor M, Mach RH, Perlmutter JS. Decreased striatal dopamine receptor binding in primary focal dystonia: A D2 or D3 defect? Movement Disorders. 26: 100-106. PMID 20960437 DOI: 10.1002/Mds.23401 |
0.394 |
|
2008 |
Antenor-Dorsey JAV, Markham J, Moerlein SM, Videen TO, Perlmutter JS. Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans Nuclear Medicine and Biology. 35: 335-341. PMID 18355689 DOI: 10.1016/J.Nucmedbio.2007.12.004 |
0.313 |
|
2008 |
Antenor-Dorsey JAV, Markham J, Moerlein SM, Videen TO, Perlmutter JS. Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans Nuclear Medicine and Biology. 35: 335-341. PMID 18355689 DOI: 10.1016/J.Nucmedbio.2007.12.004 |
0.313 |
|
2008 |
Antenor-Dorsey JAV, Laforest R, Moerlein SM, Videen TO, Perlmutter JS. Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates European Journal of Nuclear Medicine and Molecular Imaging. 35: 771-778. PMID 18071701 DOI: 10.1007/S00259-007-0644-6 |
0.343 |
|
2004 |
Mintun MA, Sheline YI, Moerlein SM, Vlassenko AG, Huang Y, Snyder AZ. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: In vivo measurement with [18F]altanserin positron emission tomography Biological Psychiatry. 55: 217-224. PMID 14744461 DOI: 10.1016/J.Biopsych.2003.08.015 |
0.34 |
|
2004 |
Moerlein SM, Perlmutter JS, Welch MJ. Radiosynthesis of (N-[11C]methyl)benperidol for PET investigation of D2 receptor binding Radiochimica Acta. 92: 333-339. DOI: 10.1524/Ract.92.4.333.35584 |
0.39 |
|
2002 |
Moerlein SM, Gaehle GG, Welch MJ. Robotic preparation of Sodium Acetate C 11 Injection for use in clinical PET Nuclear Medicine and Biology. 29: 613-621. PMID 12088733 DOI: 10.1016/S0969-8051(02)00307-4 |
0.333 |
|
2002 |
Sheline YI, Mintun MA, Moerlein SM, Snyder AZ. Greater loss of 5-HT2A receptors in midlife than in late life American Journal of Psychiatry. 159: 430-435. PMID 11870007 DOI: 10.1176/Appi.Ajp.159.3.430 |
0.311 |
|
2001 |
Moerlein SM, Welch MJ, Perlmutter JS. Synthesis and evaluation in primates of (N-[11C]methyl)-benperidol as a pet tracer of cerebral D2 receptor binding Journal of Labelled Compounds and Radiopharmaceuticals. 44: S213-S215. DOI: 10.1002/Jlcr.2580440174 |
0.409 |
|
2001 |
Moerlein SM, Perlmutter JS, Engelbach J, Sharp T, Kim JY, Rowland D, Laforest R, Mody P, Patel G, Lechner K, Welch MJ. Comparison of carbon-11 and fluorine-18 labeled (N-methyl)benperidol (NMB) in rodents using micropet imaging Journal of Labelled Compounds and Radiopharmaceuticals. 44: S455-S456. DOI: 10.1002/Jlcr.25804401160 |
0.31 |
|
1997 |
Moerlein SM, Perlmutter JS, Markham J, Welch MJ. In vivo kinetics of [18F](N-methyl)benperidol: A novel PET tracer for assessment of dopaminergic D2-like receptor binding Journal of Cerebral Blood Flow and Metabolism. 17: 833-845. PMID 9290581 DOI: 10.1097/00004647-199708000-00002 |
0.461 |
|
1997 |
Moerlein SM, Perlmutter JS, Markham J, Welch MJ. In vivo kinetics of [18F](N-methyl)benperidol: A novel PET tracer for assessment of dopaminergic D2-like receptor binding Journal of Cerebral Blood Flow and Metabolism. 17: 833-845. PMID 9290581 |
0.361 |
|
1997 |
Moerlein SM, Perlmutter JS, Cutler PD, Welch MJ. Radiation dosimetry of [18F](N-methyl)benperidol as determined by whole-body PET imaging of primates Nuclear Medicine and Biology. 24: 311-318. PMID 9257329 DOI: 10.1016/S0969-8051(97)00042-5 |
0.383 |
|
1997 |
Perlmutter JS, Stambuk MK, Markham J, Black KJ, McGee-Minnich L, Jankovic J, Moerlein SM. Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia Journal of Neuroscience. 17: 843-850. PMID 8987805 DOI: 10.1523/Jneurosci.17-02-00843.1997 |
0.426 |
|
1995 |
Moerlein SM, Perlmutter JS, Welch MJ. Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand Nuclear Medicine and Biology. 22: 809-815. PMID 8535343 DOI: 10.1016/0969-8051(95)00022-P |
0.326 |
|
1995 |
Moerlein SM, Perlmutter JS, Welch MJ. Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand Nuclear Medicine and Biology. 22: 809-815. PMID 8535343 DOI: 10.1016/0969-8051(95)00022-P |
0.447 |
|
1993 |
Moerlein SM, Gaehle GG, Lechner KR, Bera RK, Welch MJ. Automated production of oxygen-15 labeled butanol for PET measurement of regional cerebral blood flow Applied Radiation and Isotopes. 44: 1213-1218. PMID 8401450 DOI: 10.1016/0969-8043(93)90067-K |
0.32 |
|
1992 |
Moerlein SM, Perlmutter JS. Binding of 5-(2′-[18F]fluoroenthyl)flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomography European Journal of Pharmacology. 218: 109-115. PMID 1327820 DOI: 10.1016/0014-2999(92)90153-U |
0.445 |
|
1992 |
Moerlein SM, Perlmutter JS. Binding of 5-(2′-[18F]fluoroenthyl)flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomography European Journal of Pharmacology. 218: 109-115. PMID 1327820 DOI: 10.1016/0014-2999(92)90153-U |
0.308 |
|
1992 |
Moerlein SM, Banks WR, Parkinson D. Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral dopaminergic receptor binding International Journal of Radiation Applications and Instrumentation. Part. 43: 913-917. PMID 1321101 DOI: 10.1016/0883-2889(92)90155-8 |
0.454 |
|
1992 |
Moerlein SM, Perlmutter JS. Specific binding of 3N-(2′-[18F]fluoroethyl)benperidol to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET Neuroscience Letters. 148: 97-100. PMID 1300511 DOI: 10.1016/0304-3940(92)90813-M |
0.46 |
|
1992 |
Moerlein SM, Perlmutter JS. Specific binding of 3N-(2′-[18F]fluoroethyl)benperidol to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET Neuroscience Letters. 148: 97-100. PMID 1300511 DOI: 10.1016/0304-3940(92)90813-M |
0.368 |
|
1991 |
Moerlein SM, Perlmutter JS. Central serotonergic S2 binding in Papio anubis measured in vivo with N-ω-[18F]fluoroethylketanserin and PET Neuroscience Letters. 123: 23-26. PMID 2062450 DOI: 10.1016/0304-3940(91)90149-N |
0.43 |
|
1991 |
Perlmutter J, Moerlein S, Hwang D, Todd R. Non-steady-state measurement of in vivo radioligand binding with positron emission tomography: specificity analysis and comparison with in vitro binding The Journal of Neuroscience. 11: 1381-1389. DOI: 10.1523/Jneurosci.11-05-01381.1991 |
0.404 |
|
1990 |
Lannoye GS, Moerlein SM, Parkinson D, Welch MJ. N-fluoroalkylated and N-alkylated analogues of the dopaminergic D-2 receptor antagonist raclopride. Journal of Medicinal Chemistry. 33: 2430-7. PMID 2391685 |
0.302 |
|
1990 |
Moerlein SM, Parkinson D, Welch MJ. Radiosynthesis of high effective specific-activity [123I]SCH 23982 for dopamine D-1 receptor-based SPECT imaging International Journal of Radiation Applications and Instrumentation. Part. 41: 381-385. PMID 2158956 DOI: 10.1016/0883-2889(90)90147-9 |
0.372 |
|
1990 |
Gropler R, Lee K, Moerlein S, Siegel B, Geltman E. Regional variation in myocardial accumulation of 18 F-fluorodeoxyglucose in fasted normal subjects Journal of the American College of Cardiology. 15: A80. DOI: 10.1016/0735-1097(90)92035-Z |
0.324 |
|
1989 |
Moerlein SM, Brodack JW, Siegel BA, Welch MJ. Elimination of contaminant kryptofix 2.2.2 in the routine production of 2-[18F]fluoro-2-deoxy-d-glucose International Journal of Radiation Applications and Instrumentation. Part. 40: 741-743. PMID 2559062 DOI: 10.1016/0883-2889(89)90090-7 |
0.378 |
|
1989 |
Hwang D, Moerlein S, Dence C, Welch M. Microwave-facilitated synthesis of [18F]-spiperone Journal of Labelled Compounds and Radiopharmaceuticals. 26: 391-392. DOI: 10.1002/Jlcr.25802601167 |
0.342 |
|
1989 |
Lannoye G, Moerlein S, Welch M. Radiosynthesis of N-(ω-[18F]fluoroalkyl) derivatives of the dopaminergic receptor-binding ligand raclopride Journal of Labelled Compounds and Radiopharmaceuticals. 26: 340-341. DOI: 10.1002/Jlcr.25802601147 |
0.391 |
|
1989 |
Moerlein S, Welch M. Parameters affecting the labeling of 68Ga-DTPA-LDL: A potential radiopharmaceutical for in-vivo imaging of tissue low-density lipoprotein receptor activity with PET Journal of Labelled Compounds and Radiopharmaceuticals. 26: 285-286. DOI: 10.1002/Jlcr.25802601126 |
0.312 |
|
1986 |
Moerlein SM, Stöcklin G, Pawlik G, Wienhard K, Heiss WD. Regional cerebral pharmacokinetics of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as examined by positron emission tomography in a baboon is altered by tranylcypromine Neuroscience Letters. 66: 205-209. PMID 3487753 DOI: 10.1016/0304-3940(86)90191-6 |
0.361 |
|
1986 |
Moerlein SM, Laufer P, Stöcklin G, Pawlik G, Wienhard K, Heiss WD. Evaluation of 75Br-labelled butyrophenone neuroleptics for imaging cerebral dopaminergic receptor areas using positron emission tomography European Journal of Nuclear Medicine. 12: 211-216. PMID 2876896 DOI: 10.1007/Bf00256924 |
0.418 |
|
1985 |
Moerlein SM, Laufer P, Stocklin G. Effect of lipophilicity on the in vivo localization of radiolabelled spiperone analogues International Journal of Nuclear Medicine and Biology. 12: 353-356. PMID 3833821 DOI: 10.1016/S0047-0740(85)80003-6 |
0.362 |
|
Show low-probability matches. |